High levels of the neurotransmitters serotonin and oxytocin are related to prosocial behavior.

Recommended textbook solutions

High levels of the neurotransmitters serotonin and oxytocin are related to prosocial behavior.

Social Psychology

10th EditionElliot Aronson, Robin M. Akert, Samuel R. Sommers, Timothy D. Wilson

525 solutions

High levels of the neurotransmitters serotonin and oxytocin are related to prosocial behavior.

Social Psychology

10th EditionElliot Aronson, Robin M. Akert, Timothy D. Wilson

525 solutions

High levels of the neurotransmitters serotonin and oxytocin are related to prosocial behavior.

Social Psychology and Human Nature

5th EditionBrad J. Bushman, Roy F. Baumeister

374 solutions

High levels of the neurotransmitters serotonin and oxytocin are related to prosocial behavior.

Social Psychology

10th EditionElliot Aronson, Robin M. Akert, Samuel R. Sommers, Timothy D. Wilson

525 solutions

1. Zucker NL., Losh M., Bulik CM., LaBar KS., Piven J., Pelphrey KA. Anorexia nervosa and autism spectrum disorders: guided investigation of social cognitive endophenotypes. Psychol Bull.2007;133(6):976–1006. [PubMed] [Google Scholar]

2. de Jong JJ., de Gelder B., Hodiamont PP. Sensory processing, neurocognition, and social cognition in schizophrenia: towards a cohesive cognitive model. Schizophr Res.2013;146(1-3):209–216. [PubMed] [Google Scholar]

3. Miskovic V., Schmidt LA. Social tearfulness in the human brain. Neurosci Biobehav Rev.2012;36:459–478. [PubMed] [Google Scholar]

4. Valkanova V., Rhodes F., Allan CL. Diagnosis and management of autism in adults. Practitioner.2013;257(1761):13–16. [PubMed] [Google Scholar]

5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Press. . 2013 [Google Scholar]

6. Al-Asadi AM., Klein B. Multiple comorbidities of 21 psychological disorders and relationships with psychosocial variables: a study of the online assessment and diagnostic system within a web-based population. J Med Internet Res.2015;17(2):e55. [PMC free article] [PubMed] [Google Scholar]

7. Achim AM., Maziade M., Raymond E., Oliver D., Merette C., Roy MA. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull.2011;37(4):811–821. [PMC free article] [PubMed] [Google Scholar]

8. Beidel DC., Turner SM. Shy Children, Phobic Adults: Nature and Treatment of Social Anxiety Disorder. 2nd ed. Washington, DC: American Psychological Association. 2013 [Google Scholar]

9. Fox AS., Kalin NH. A translational neuroscience approach to understanding the development of social anxiety disorder and its pathophysiology. Am J Psychiatry.2014;171(11):1162–1173. [PMC free article] [PubMed] [Google Scholar]

10. Pilling S., Mayo-Wilson E., Mavranezouli I., Kew K., Taylor C., Clark DM. Guideline Development Group. Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance. BMJ.2013;346:f2541. [PubMed] [Google Scholar]

11. Stein MB., Stein DJ. Social anxiety disorder. Lancet.2008;371(9618):1115–1125. [PubMed] [Google Scholar]

12. Rhodes CH., Morriell JI., Pfaff DW. Irnmunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin. J Comp Neurol.1981;198(1):45–64. [PubMed] [Google Scholar]

13. Viero C., Shibuya I., Kitamura N., et al Oxytocin: crossing the bridge between basic science and pharmacotherapy. CNS Neurosci Ther.2010;16(5):e138–e156. [PMC free article] [PubMed] [Google Scholar]

14. Lee HJ., Macbeth AH., Pagani J., Young WS. Oxytocin: the great facilitator of life. Prog Neurobiol.2009;88(2):127–151. [PMC free article] [PubMed] [Google Scholar]

15. Yamasue H., Yee JR., Hurlemann R., Rilling JK., Chen FS., Meyer-Lindenberg A. Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction. J Neurosci.2012;32(41):14109–14117. [PMC free article] [PubMed] [Google Scholar]

16. Carter CS. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology.1998;23(8):779–818. [PubMed] [Google Scholar]

17. Porges SW. The polyvagal theory: phylogenetic contributions to social behavior. Physiol Behav.2003;79(3):503–513. [PubMed] [Google Scholar]

18. Pedersen CA., Prange AJ. Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin. Proc Natl Acad Sci U S A.1979;76(12):6661–6665. [PMC free article] [PubMed] [Google Scholar]

19. Insel TR., Young L., Wang Z. Molecular aspects of monogamy. Ann N Y Acad Sci.1997;807:302–316. [PubMed] [Google Scholar]

20. Williams JR., Insel TR., Harbaugh CR., Carter CS. Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles . (Microtus ochrogaster). J Neuroendocrinol.1994;6(3):247–250. [PubMed] [Google Scholar]

21. Young LJ., Wang Z. The neurobiology of pair bonding. Nat Neurosci.2004;7(10):1048–1054. [PubMed] [Google Scholar]

22. Carter CS., Grippo AJ., Pournajafi-Nazarloo H., Ruscio MG., Porges SW. Oxytocin, vasopressin and sociality. Prog Brain Res.2008;170:331–336. [PubMed] [Google Scholar]

23. Young LJ., Lim MM., Gingrich B., Insel TR. Cellular mechanisms of social attachment. Horm Behav.2001;40(2):133–138. [PubMed] [Google Scholar]

24. Ross HE., Young LJ. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front Neuroendocrinol.2009;30(4):534–547. [PMC free article] [PubMed] [Google Scholar]

25. Lukas M., Neumann ID. Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders. Behav Brain Res.2013;251:85–94. [PubMed] [Google Scholar]

26. Benelli A., Bertolini A., Poggioli R., Menozzi B., Basaglia R., Arletti R. Polymodal dose-response curve for oxytocin in the social recognition test. Neuropeptides.1995;28(4):251–255. [PubMed] [Google Scholar]

27. Engelmann M., Ebner K., Wotjak CT., Landgraf R. Endogenous oxytocin is involved in short-term olfactory memory in female rats. Behav Brain Res.1998;90(1):89–94. [PubMed] [Google Scholar]

28. Lukas M., Toth I., Veenema AH., Neumann ID. Oxytocin mediates rodent social memory within the lateral septum and the medial amygdala depending on the relevance of the social stimulus: male juvenile versus female adult conspecifics. Psychoneuroendocrinology.2013;38(6):916–926. [PubMed] [Google Scholar]

29. van Wimersma Greidanus TB., Maigret C. The role of limbic vasopressin and oxytocin in social recognition. Brain Res.1996;713(1-2):153–159. [PubMed] [Google Scholar]

30. Popik P., van Ree JM. Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain. Eur Neuropsychopharmacol.1991;1(4):555–560. [PubMed] [Google Scholar]

31. Popik P., Vos PE., Van Ree JM. Neurohypophyseal hormone receptors in the septum are implicated in social recognition in the rat. Behav Pharmacol.1992;3(4):351–358. [PubMed] [Google Scholar]

32. Dluzen DE., Muraoka S., Engelmann M., Landgraf R. The effects of infusion of arginine vasopressin, oxytocin, or their antagonists into the olfactory bulb upon social recognition responses in male rats. Peptides.1998;19(6):999–1005. [PubMed] [Google Scholar]

33. Larrazolo-Lopez A., Kendrick KM., Aburto-Arciniega M., et al Vaginocervical stimulation enhances social recognition memory in rats via oxytocin release in the olfactory bulb. Neuroscience.2008;152(3):585–593. [PubMed] [Google Scholar]

34. Choleris E., Little SR., Mong JA., Puram SV., Langer R., Pfaff DW. Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice. Proc Natl Acad Sci U S A.2007;104(11):4670–4675. [PMC free article] [PubMed] [Google Scholar]

35. Engelmann M., Wotjak CT., Neumann I., Ludwig M., Landgraf R. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav Rev.1996;20(3):341–358. [PubMed] [Google Scholar]

36. Carter CS., Altemus M. Integrative functions of lactational hormones in social behavior and stress management. Ann N Y Acad Sci.1997;807:164–174. [PubMed] [Google Scholar]

37. Young LJ. The neurobiology of social recognition, approach, and avoidance. Biol Psychiatry.2002;51(1):18–26. [PubMed] [Google Scholar]

38. Olff M., Frijling JL., Kubzansky LD., et al The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences. Psychoneuroendocrinology.2013;38(9):1883–1894. [PubMed] [Google Scholar]

39. Neumann ID., Krömer SA., Toschi N., Ebner K. Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions. Regul Pept.2000;96(1-2):31–38. [PubMed] [Google Scholar]

40. Neumann ID. Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis. Prog Brain Res.2002;139:147–162. [PubMed] [Google Scholar]

41. Huber D., Veinante P., Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science.2005;308(5719):245–248. [PubMed] [Google Scholar]

42. Viviani D., Charlet A., van den Burg E., et al Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science.2011;333(6038):104–107. [PubMed] [Google Scholar]

43. Gibbs DM. Dissociation of oxytocin, vasopressin, and corticotropin secretion during different types of stress. Life Sci.1984;35(5):487–491. [PubMed] [Google Scholar]

44. Williams TD., Carter DA., Lightman SL. Sexual dimorphism in the posterior pituitary response to stress in the rat. Endocrinology.1985;116(2):738–740. [PubMed] [Google Scholar]

45. Lang RE., Heil JW., Ganten D., Hermann K., Unger T., Rascher W. Oxytocin unlike vasopressin is a stress hormone in the rat. Neuroendocrinology.1983;37(4):314–316. [PubMed] [Google Scholar]

46. Onaka T., Yagi K. Effects of novelty stress on vasopressin and oxytocin secretion by the pituitary in the rat. J Neuroendocrinol.1993;5(4):365–369. [PubMed] [Google Scholar]

47. Jezova D., Skultetyova I., Tokarev DI., Bakos P., Vigas M. Vasopressin and oxytocin in stress. Ann N Y Acad Sci.1995;771:192–203. [PubMed] [Google Scholar]

48. Wotjak CT., Ganster J., Kohl G., Holsboer F., Landgraf R., Engelmann M. Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons. Neuroscience.1998;85(4):1209–1222. [PubMed] [Google Scholar]

49. Neumann ID., Slattery DA. Oxytocin in general anxiety and social fear: a translational approach. Biol Psychiatry.2016;79(3):213–221. [PubMed] [Google Scholar]

50. Bale TL., Davis AM., Auger AP., Dorsa DM., McCarthy MM. CNS regions-pecific oxytocin receptor expression: importance in regulation of anxiety and sex behavior. J Neurosci.2001;21(7):2546–2552. [PMC free article] [PubMed] [Google Scholar]

51. Blume A., Bosch OJ., Miklos S., et al Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci.2008;27(8):1947–1956. [PubMed] [Google Scholar]

52. Jurek B., Slattery DA., Maloumby R., et al Differential contribution of hypothalamic MAPK activity to anxiety-like behaviour in virgin and lactating rats. PLoS One.2012;7(5):e37060. [PMC free article] [PubMed] [Google Scholar]

53. Sabihi S., Durosko NE., Dong SM., Leuner B. Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats. Psychoneuroendocrinology.2014;45:31–42. [PMC free article] [PubMed] [Google Scholar]

54. Peters S., Slattery DA., Uschold-Schmidt N., Reber SO., Neumann ID. Dose-dependent effects of chronic central infusion of oxytocin on anxiety, oxytocin receptor binding and stress-related parameters in mice. Psychoneuroendocrinology. 2014;42:225–236. [PubMed] [Google Scholar]

55. Windle RJ., Shanks N., Lightman SL., Ingram CD. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology.1997;138(7):2829–2834. [PubMed] [Google Scholar]

56. Chang SW., Platt ML. Oxytocin and social cognition in rhesus macaques: implications for understanding and treating human psychopathology. Brain Res.2014;1580:57–68. [PMC free article] [PubMed] [Google Scholar]

57. Freeman SM., Inoue K., Smith, Goodman MM., Young LJ. The neuroanatomical distribution of oxytocin receptor binding and mRNA in the male rhesus macaque (Macaca mulatta). Psychoneuroendocrinology.2014;45:128–141. [PMC free article] [PubMed] [Google Scholar]

58. Winslow JT., Noble PL., Lyons CK., Sterk SM., Insel TR. Rearing effects on cerebrospinal fluid oxytocin concentration and social buffering in rhesus monkeys. Neuropsychopharmacology.2003;28(5):910–918. [PubMed] [Google Scholar]

59. Chang SW., Barter JW., Ebitz RB., Watson KK., Platt ML. Inhaled oxytocin amplifies both vicarious reinforcement and self reinforcement in rhesus macaques (Macaca mulatta). Proc Natl Acad Sci U S A.2012;109(3):959–964. [PMC free article] [PubMed] [Google Scholar]

60. Ebitz RB., Watson KK., Platt ML. Oxytocin blunts social vigilance in the rhesus macaque. Proc Natl Acad Sci U S A.2013;110(28):11630–11635. [PMC free article] [PubMed] [Google Scholar]

61. Parr LA., Modi M., Siebert E., Young LJ. Intranasal oxytocin selectively attenuates rhesus monkeys' attention to negative facial expressions. Psychoneuroendocrinology.2013;38(9):1748–1756. [PMC free article] [PubMed] [Google Scholar]

62. Lai MC., Lombardo MV., Baron-Cohen S. Autism. Lancet.2014;383(9920): 896–910. [PubMed] [Google Scholar]

63. Schneier FR., Rodebaugh TL., Blanco C., Lewin H., Liebowitz MR. Fear and avoidance of eye contact in social anxiety disorder. Compr Psychiatry.2011;52(1):81–87. [PubMed] [Google Scholar]

64. Bogels SM., Mansell W. Attention processes in the maintenance and treatment of social phobia: hypervigilance, avoidance and self-focused attention. Clin Psychol Rev.2004;24(7):827–856. [PubMed] [Google Scholar]

65. Hyman SE. Stress and the Brain: the Science of Mental Health. London, UK: Taylor & Francis; 2013 [Google Scholar]

66. Simpson EA., Sclafani V., Paukner A., Hamel AF., Novak MA., Meyer JS. Inhaled oxytocin increases positive social behaviors in newborn macaques. Proc Natl Acad Sci U S A.2014;111(19):6922–6927. [PMC free article] [PubMed] [Google Scholar]

67. Alvares GA., Chen NT., Balleine BW., Hickie IB., Guastella AJ. Oxytocin selectively moderates negative cognitive appraisals in high trait anxious males. Psychoneuroendocrinology.2012;37(12):2022–2031. [PubMed] [Google Scholar]

68. Cardoso C., Linnen AM., Joober R., Ellenbogen MA. Coping style moderates the effect of intranasal oxytocin on the mood response to interpersonal stress. Exp Clin Psychopharmacol.2012;20(2):84–91. [PubMed] [Google Scholar]

69. Labuschagne I., Phan KL., Wood A., et al Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology.2010;35(12):2403–2413. [PMC free article] [PubMed] [Google Scholar]

70. Kawamura Y., Liu X., Akiyama T., et al The association between oxytocin receptor gene (OXTR) polymorphisms and affective temperaments, as measured by TEMPS-A. J Affect Disord.2010;127(1-3):31–37. [PubMed] [Google Scholar]

71. LoParo D., Waldman ID. The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis. Mol Psychiatry.2015;20(5):640–646. [PubMed] [Google Scholar]

72. Saphire-Bernstein S., Way BM., Kim HS., Sherman DK., Taylor SE. Oxytocin receptor gene (OXTR) is related to psychological resources. Proc Natl Acad Sci U S A.2011;108(37):15118–151122. [PMC free article] [PubMed] [Google Scholar]

73. Kumsta R., Hummel E., Chen FS., Heinrichs M. Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience. Front Neurosci.2013;7:83. [PMC free article] [PubMed] [Google Scholar]

74. Saphire-Bernstein S., Way BM., Kim HS., Sherman DK., Taylor SE. Oxytocin receptor gene (OXTR) is related to psychological resources. Proc Natl Acad Sci U S A.2011;108(37):15118–15122. [PMC free article] [PubMed] [Google Scholar]

75. Ziegler C., Dannlowski U., Bräuer D., Stevens S., Laeger I., Wittmann H. Oxytocin receptor gene methylation: converging multilevel evidence for a role in social anxiety. Neuropsychopharmacology.2015;40(6):1528–1538. [PMC free article] [PubMed] [Google Scholar]

76. Hoge EA., Pollack MH., Kaufman RE., Zak PJ., Simon NM. Oxytocin levels in social anxiety disorder. CNS Neurosci Ther.2008;14(3):165–170. [PMC free article] [PubMed] [Google Scholar]

77. Marazziti D., Baroni S., Catena M., et al A relationship between social anxiety and oxytocin. Eur Psychiatry.2007;22:S281–S282. [Google Scholar]

78. Labuschagne I., Phan KL., Wood A., et al Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology.2010;35(12):2403–2413. [PMC free article] [PubMed] [Google Scholar]

79. Phan KL., Fitzgerald DA., Nathan PJ., Tancer ME. Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalised social phobia. Biol Psychiatry.2006;59(4):424–429. [PubMed] [Google Scholar]

80. Huber D., Veinante P., Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science.2005;308(5719):245–248. [PubMed] [Google Scholar]

81. Labuschagne I., Phan KL., Wood A., et al Medial frontal hyperactivity to sad faces in generalized social anxiety disorder and modulation by oxytocin. Int J Neuropsychopharmacol.2012;15(7):883–896. [PubMed] [Google Scholar]

82. Gorka SM., Fitzgerald DA., Labuschagne I., et al Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder. Neuropsychopharmacology.2015;40(2):278–286. [PMC free article] [PubMed] [Google Scholar]

83. Dodhia S., Hosanagar A., Fitzgerald DA., Labuschagne I., Wood AG., Nathan PJ. Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder. Neuropsychopharmacology.2014;39(9):2061–2069. [PMC free article] [PubMed] [Google Scholar]

84. Guastella AJ., Howard AL., Dadds MR., Mitchell P., Carson DS. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology.2009;34(6):917–923. [PubMed] [Google Scholar]

85. Levinson CA., Rodebaugh TL. Social anxiety and eating disorder comorbidity: the role of negative social evaluation fears. Eat Behav.2012;13(1):27–35. [PMC free article] [PubMed] [Google Scholar]

86. Foussias G., Agid O., Fervaha G., Remington G. Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders. Eur Neuropsychopharmacol.2014;24(5):693–709. [PubMed] [Google Scholar]

87. Feifel D., Macdonald K., Nguyen A., Cobb P., Warlan H., Galangue B. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry.2010;68(7):678–680. [PubMed] [Google Scholar]

88. Feifel D., Shilling D., MacDonald K. A review of oxytocin's effects on the positive, negative, and cognitive domains of schizophrenia. Biol Psychiatry.2015;79(3):222–223. [PMC free article] [PubMed] [Google Scholar]

89. Averbeck, Bobin T., Evans S., Shergill SS. Emotion recognition and oxytocin in patients with schizophrenia. Psychol Med.2012;42(2):259–266. [PMC free article] [PubMed] [Google Scholar]

90. Davis MC., Lee J., Horan WP., et al Effects of single dose intranasal oxytocin on social cognition in schizophrenia. Schizophr Res.2013;147(2-3):393–397. [PubMed] [Google Scholar]

91. Preti A., Melis M., Siddi S., Vellante M., Doneddu G., Fadda R. Oxytocin and autism: a systematic review of randomized controlled trials. J Child Adolesc Psychopharmacol.2014;24(2):54–68. [PubMed] [Google Scholar]

92. Andari E., Duhamel JR., Zalla T., Herbrecht E., Leboyer M., Sirigu A. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci U S A.2010;107(9):4389–4394. [PMC free article] [PubMed] [Google Scholar]

93. Hollander E., Bartz J., Chaplin W., et al Oxytocin increases retention of social cognition in autism. Biol Psychiatry.2007;61(4):498–503. [PubMed] [Google Scholar]

94. Guastella AJ., Einfeld SL., Gray KM., et al Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry.2010;67(7):692–694. [PubMed] [Google Scholar]

95. de Lacy N., King BH. Revisiting the relationship between autism and schizophrenia: toward an integrated neurobiology. Annu Rev Clin Psychol.2013;9:555–587. [PubMed] [Google Scholar]

96. Kim YR., Kim CH., Cardi V., Eom JS., Seong Y., Treasure J. Intranasal oxytocin attenuates attentional bias for eating and fat shape stimuli in patients with anorexia nervosa. Psychoneuroendocrinology.2014;44:133–142. [PubMed] [Google Scholar]

97. Kim YR., Kim CH., Park JH., Pyo J., Treasure J. The impact of intranasal oxytocin on attention to social emotional stimuli in patients with anorexia nervosa: a double blind within-subject cross-over experiment. PLoS One.2014;9(6):e90721. [PMC free article] [PubMed] [Google Scholar]

98. Kim YR., Eom JS., Yang JW., Kang J., Treasure J. The impact of oxytocin on food intake and emotion recognition in patients with eating disorders: a double blind single dose within-subject cross-over design. PLoS One.2015;10(9):e0137514. [PMC free article] [PubMed] [Google Scholar]

99. Insel TR. Translating oxytocin neuroscience to the clinic: a national institute of mental health perspective. Biol Psychiatry.2015;79(1):153–154. [PubMed] [Google Scholar]

100. Lawson EA., Holsen LM., Santin M., et al Postprandial oxytocin secretion is associated with severity of anxiety and depressive symptoms in anorexia nervosa. J Clin Psychiatry.2014;74(5):e451–e457. [PMC free article] [PubMed] [Google Scholar]

101. Guastella AJ., Hickie IB., McGuinness MM., et al Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research. Psychoneuroendocrinology.2013;38(5):612–625. [PubMed] [Google Scholar]

102. Evans SL., Dal Monte O., Noble P., Averbeck BB. Intranasal oxytocin effects on social cognition: a critique. Brain Res.2014;1580:69–77. [PMC free article] [PubMed] [Google Scholar]

103. Ermisch A., Rühle HJ., Landgraf R., Hess J. Blood-brain barrier and peptides. J Cereb Blood Flow Metab.1985;5(3):350–357. [PubMed] [Google Scholar]

104. Kelly AM., Goodson JL. Social functions of individual vasopressin-oxytocin cell groups in vertebrates: what do we really know? Front Neuroendocrinol.2014;35(4):512–529. [PubMed] [Google Scholar]

Which neurotransmitter is associated with prosocial behavior?

Abstract. Decades of research have linked the neurotransmitter serotonin (5-HT) to prosocial behavior.
We found that oxytocin increased prosocial helping behavior toward the excluded person, possibly because of enhanced empathic feelings and understanding of the emotions of the victim and an increased willingness to take social risks.
Personal benefits: Prosocial behaviors are often seen as being compelled by a number of factors including egoistic reasons (doing things to improve one's self-image), reciprocal benefits (doing something nice for someone so that they may one day return the favor), and more altruistic reasons (performing actions purely ...

How does serotonin influence behavior?

In both primates and humans, serotonin function tends to covary positively with prosocial behaviors such as grooming, cooperation, and affiliation, and tends to covary negatively with antisocial behaviors such as aggression and social isolation.